FINWIRES · TerminalLIVE
FINWIRES

Cantor Fitzgerald Adjusts Price Target on Regeneron Pharmaceuticals to $779 From $800, Maintains Overweight Rating

作者

-- Regeneron Pharmaceuticals (REGN) has an average rating of overweight and mean price target of $886.38, according to analysts polled by FactSet.

(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

Price: $690.03, Change: $-41.75, Percent Change: -5.70%

相关文章